Established 1880 - World's #1 Company for Original Stock Certificates & RM Smythe Old Stock Research Services - Rated A+ by Better Business Bureau

Historic Stock & Bond Certificates                                                                              
RM Smythe Stock Research Since 1880                                                                          

Free Shipping for All Domestic USA Orders
Everything on Sale - Buy Now and Save

Stock Certificates Make Great Gifts
Scripophily is the Gift of History

What our customers say:


Schering - Plough Pharmaceutical Company  

Schering - Plough Pharmaceutical Company

Product #: schercorstoc

Normal Price: $59.95
Our Sales Price: $39.95

(You Save: 33%)


Beautifully engraved certificate from the Schering-Plough Corporation issued in 1971. This historic document was printed by the Security-Columbian Banknote Company and has an ornate border with a vignette of an allegorical woman sitting in front of labratory beakers next to two world globes. This item has the printed signatures of the Company’s President and Secretary. is a name you can TRUST!
Certificate Vignette

Schering-Plough is a worldwide pharmaceutical company committed to discovering, developing and marketing new therapies and treatment programs that can improve people's health and save lives.

The Company is also a recognized leader in biotechnology, genomics and gene therapy.

Core product groups are allergy/respiratory, anti-infective/anticancer, dermatologicals and cardiovasculars. Pharmaceutical product lines are complemented by

health management programs, a growing worldwide animal health business as well as leading consumer brands of sun care, foot care and over-the-counter products.

Innovative research, effective marketing and solid financial management have enabled the Company to achieve significant sales growth, deliver superior financial results and reward shareholders.

Schering Corporation was first established in the late 1800s as the U.S. subsidiary of Schering AG, a German-based pharmaceutical and chemical company. In 1928, Schering Corporation was incorporated in New York City and in 1935 in New Jersey. Schering Corporation initially offered a modest but promising line of pharmaceutical products to U.S. consumers, which led to steady growth and a rapid expansion of facilities.

The 1940s proved to be a key decade in the history of the company, as it evolved from a European-based company with U.S. operations into a truly American enterprise. Schering Corporation had been nationalized by the U.S. government during World Wars I and II, and in 1952 the company passed into the private sector.

For Schering, the 1950s and 1960s were characterized by continued growth, attributable to research and development and acquisition activities. Schering Corporation grew to become a global research-based pharmaceutical firm, and in 1971, merged with Plough Inc., a worldwide manufacturer of consumer products, to create Schering-Plough Corporation. The merger proved successful, as only a decade later the company’s sales had grown fourfold.

In the 1980s and 1990s, Schering-Plough refined its focus on four key therapeutic areas and continued to excel at innovative approaches to treating disease. New research technologies acquired during this time quickly became important tools in Schering-Plough’s research program, enabling the company to achieve important pharmaceutical advances and significant breakthroughs in antihistamines, corticosteroids, antibiotics, anti-infectives and antiviral products. Over the years, Schering-Plough also has divested and acquired businesses and entered into alliances to strengthen its worldwide competitiveness.

From its modest beginnings to its presence in more than 125 countries today, Schering-Plough has been guided by a strategy based on growth through research for more than 50 years. Combined with solid financial management and marketing excellence, this strategy has enabled Schering-Plough to succeed in today’s competitive environment and develop new products with the potential to improve people’s health and extend lives.

History from company's press information.

Product #: schercorstoc

Normal Price: $59.95
Our Sales Price: $39.95

(You Save: 33%)

Qty: and Old Company Research Press Releases

See Stock Certificate Expert Bob Kerstein, CEO
discuss Stock Certificates in Bloomberg ,  the Associated Press ,
CNBC with Jane Wells discussing the Facebook IPO,
Inside Edition and the Today Show

Subscribe to our New Free RSS New Products Feed in a Reader

Subscribe to Our New Product Additions Feed by Email

We will always maintain our founding commitment to customer satisfaction and the delivery of an exceptional product with an enjoyable shopping experience.  Please let us know how we may be of service to you. Stay Safe!!!

Scripophily has been
fully tested by
Norton Safe

E-Mail Subscription for Scripophily Stock and Bond News - No Charge

Bookmark and Share

Scripophily has been featured on CNN, CNBC, CBS, WSJ, Barrons, and many other fine publications
See in the News at

All Old Stock and Bond Certificates are actual authentic certificates and are sold only as collectibles. We do not sell reproductions and offer a lifetime guarantee to the authenticity of everything we sell.

All Rights Reserved. © 1996 - 2021 is a name you can TRUST!
American Institute of
Certified Public Accountants is a name you can TRUST!
Virginia Society CPA's
Bob Kerstein, Member
Click to Verify Trust Certificate - Yahoo is a licensee of the TRUSTe� Privacy Seal Program is a name you can TRUST!
American Numismatic Association

Securities and Exchange
Commission Historical Society

Society of Paper Money Collectors
Member - Gift of History -  BBB Membership Seal
Better Business
 Bureau Member
Rated A+